Boundless Bio, Inc. financial data

Symbol
BOLD on Nasdaq
Location
10955 Alexandria Way, Suite 100, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.77K %
Return On Equity -44.8 % -140%
Return On Assets -34.2 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22.4M shares +0.59%
Common Stock, Shares, Outstanding 22.4M shares +0.59%
Entity Public Float 68.4M USD
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 22.4M shares +1.51%
Weighted Average Number of Shares Outstanding, Diluted 22.4M shares +1.51%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 51.8M USD +3.68%
General and Administrative Expense 19.6M USD +30%
Operating Income (Loss) -71.4M USD -9.8%
Nonoperating Income (Expense) 7.01M USD -4.04%
Net Income (Loss) Attributable to Parent -64.4M USD -11.6%
Earnings Per Share, Basic 7 USD/shares +9.09%
Earnings Per Share, Diluted 7 USD/shares +9.09%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 14.7M USD -53.1%
Cash, Cash Equivalents, and Short-term Investments 127M USD -29.1%
Assets, Current 130M USD -29.2%
Property, Plant and Equipment, Net 3.79M USD +1.47%
Operating Lease, Right-of-Use Asset 45.4M USD +5917%
Assets 179M USD -4.65%
Accounts Payable, Current 2.29M USD +36.1%
Employee-related Liabilities, Current 1.4M USD -32%
Liabilities, Current 9.21M USD +2.86%
Operating Lease, Liability, Noncurrent 47.5M USD
Liabilities 56.8M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -4K USD +93.8%
Retained Earnings (Accumulated Deficit) -233M USD -38.2%
Stockholders' Equity Attributable to Parent 123M USD -31.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 123M USD -31.6%
Liabilities and Equity 179M USD -4.65%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.5M USD +7.9%
Net Cash Provided by (Used in) Investing Activities 3.06M USD -83.1%
Common Stock, Shares Authorized 700M shares 0%
Common Stock, Shares, Issued 22.4M shares +0.59%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.5M USD -898%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 15.3M USD -52.2%
Deferred Tax Assets, Valuation Allowance 58.8M USD +53.5%
Deferred Tax Assets, Gross 72.1M USD +84.9%
Payments to Acquire Property, Plant, and Equipment 59K USD -28.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -64.3M USD -11.6%
Property, Plant and Equipment, Gross 8.14M USD +16.3%
Operating Lease, Liability, Current 1.96M USD +134%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Deferred Tax Assets, Operating Loss Carryforwards 27.6M USD +50.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 70M shares 0%
Unrecognized Tax Benefits 9.21M USD +14.5%
Operating Lease, Payments 100K USD -85.7%
Additional Paid in Capital 356M USD +2.24%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 317K USD +20.5%
Deferred Tax Assets, Net of Valuation Allowance 13.3M USD +1844%
Share-based Payment Arrangement, Expense 7.54M USD +43.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%